Sherman Oaks, CA, United States of America

Berhan Mandefro

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Berhan Mandefro: Innovator in Neuromuscular Junction Research

Introduction

Berhan Mandefro is a notable inventor based in Sherman Oaks, California. He has made significant contributions to the field of neuromuscular junction research. His innovative work focuses on the interaction between motor neuron cells and skeletal muscle cells, which has important implications for understanding various neuromuscular diseases.

Latest Patents

Berhan Mandefro holds a patent related to the culturing of motor neuron cells alongside skeletal muscle cells in a fluidic device. This invention, known as the NMJ-on-chip, allows for the simulation of the structure and function of the neuromuscular junction. The patent highlights the good viability and functionality of skeletal muscle cells on fluidic chips, enabling measurements of muscle cell contractions. This technology is particularly valuable for modeling diseases that affect neuromuscular junctions, such as Amyotrophic lateral sclerosis (ALS). He has 1 patent to his name.

Career Highlights

Mandefro is currently affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in neuromuscular junctions. His work is at the forefront of medical innovation, contributing to a deeper understanding of neuromuscular diseases and potential therapeutic approaches.

Collaborations

He collaborates with esteemed colleagues, including Dhruv Sareen and Anjoscha Kaus. Their combined expertise enhances the research efforts at Cedars-Sinai Medical Center, fostering an environment of innovation and discovery.

Conclusion

Berhan Mandefro's contributions to neuromuscular junction research exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for future treatments of debilitating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…